<DOC>
	<DOCNO>NCT01132560</DOCNO>
	<brief_summary>RATIONALE : Studying sample tumor tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This research study study biomarkers tissue sample patient ductal breast carcinoma situ .</brief_summary>
	<brief_title>Biomarkers Tissue Samples From Patients With Ductal Breast Carcinoma Situ</brief_title>
	<detailed_description>OBJECTIVES : - To validate prognostic utility Oncotype DX Recurrence Score® assay tissue sample patient ductal breast carcinoma situ enrol clinical trial ECOG-E5194 . OUTLINE : RNA extract archived tissue sample analyze gene expression profile Oncotype DX Recurrence Score® assay ( reverse transcriptase-PCR-based assay ) .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Carcinoma , Ductal , Breast</mesh_term>
	<mesh_term>Carcinoma , Intraductal , Noninfiltrating</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis ductal breast carcinoma situ Enrolled clinical trial ECOGE5194 Local surgery without radiotherapy Treated treat tamoxifen Available tissue sample Hormone receptor status specify PATIENT CHARACTERISTICS : Menopausal status specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>ductal breast carcinoma situ</keyword>
</DOC>